DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
Capravirine is an investigational drug.
There have been 9 clinical trials for Capravirine. The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 1999.
The most common disease conditions in clinical trials are HIV Infections, Acquired Immunodeficiency Syndrome, and Communicable Diseases. The leading clinical trial sponsors are Agouron Pharmaceuticals, Pfizer, and National Institute of Allergy and Infectious Diseases (NIAID).
Recent Clinical Trials for Capravirine
|Four-Drug Combination Treatment in Hiv-Infected Subjects Failing Therapy With Antiretroviral Regimens||Pfizer||Phase 2|
|Capravirine (AG1549) in Combination With Viracept and Two NRTIs in HIV Infected Patients Who Failed an Initial NNRTI Containing Regimen||Pfizer||Phase 2|
|Capravirine to Treat Children With HIV Infection||National Cancer Institute (NCI)||Phase 1|